Gonorrhoea accounts for over 82 million new cases each year and has had no new treatment in more than 40 years.
GARDP and Innoviva Specialty Therapeutics have co-developed zoliflodacin, an investigational first-in-class oral antibiotic now under FDA review.
THIS IS BIG.
#WAAW2025 #AMR 
